Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to FDA guidelines, as a pre-marketing condition for release in the USA.
Bad economic conditions, e.g. a recession, at the time of birth may lead to a higher risk of cardiovascular mortality much later in life, according to a recent study published by researchers at the Institute for the Study of Labour (IZA) in Bonn.
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
The world's first symposium on the molecular analysis of sudden death syndrome (SDS) among athletes drew in leading cardiovascular researchers and several top Spanish footballers. Sponsored by Applied Biosystems, and held in the Madrid's Hospital Clinico San Carolos, the I Symposium de Prevención en el Futbol aims to initiate the development of new tests to identify sports players at SDS risk.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
The contraction of the atria and ventricles is differentially regulated, according to a study by Rodolphe Fischmeister and colleagues, at INSERM UMR-S 769 in Châtenay-Malabry.
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.
This year sees the fifth anniversary of EuroPRevent.
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Every summer the European Society of Cardiology (ESC) holds Europe's biggest annual meeting of specialists in cardiovascular medicine, inviting and drawing in top international medical professionals. Karoline Laarmann asked Professor Kim Fox, President of the European Society of Cardiology and Consultant Cardiologist at the Royal Brompton Hospital, and professor of clinical cardiology at Imperial…
Medicine is not earthly anymore. The first defibrillator has reached the International Space Station (ISS). LIFEPAK 1000 developed by Physio-Control of Redmond will be available for NASA crew members in case of a sudden cardiac arrest in space.
Do we have to create a food guide for people? The European Parliament already proposed this suggestion to protect people from getting cardiovascular diseases. This week experts will discuss the issue at the annual ESC Congress. They believe the UK traffic light system might help people keep more attention to nutrition
British researchers found that the NHS and private healthcare are not providing good enough basic care to a large portion of the population in England. Particulary older and frailer people are suffering from lack of care.
A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive angioplasty.
The probability of woman of suffering from cardiovascular diseases is often underestimated. A recent study evaluated the risk of nearly 9.000 women in the U.S. screened for heart-health risk: one in five women had a higher risk than measured by a frequently used predictor.
A pressure sensor that is implanted into the heart works with an electronic monitoring system that wirelessly measures patient's pulmonary artery pressure. It allows physicians to track the patient's pulmonary artery pressure while they remain at home
Hospital admission might probably determine the severity of heart failure. By analysing data from 260 hospitals across the United States researchers created a model to reduce in-hospital mortality and more quickly identify triage methods and treatment decisions.
Compared to 1997 people aged 60 and over receive a lot more from their physicians: Not more attention but more drugs or other medical aids. The average number of prescriptions for elder people doubled from 1997 to 2007, a report from The NHS Information Centre reveals.
Treadmill exercise testing is a common tool to detect of cardiovascular diseases. But clear images of the working heart are hard to obtain. Now researchers designed MRI equipment to provide high-resolution images of the heart at critical stages.
Tiny lipid-shelled microbubbles injected in vessels may serve as an new ultrasound contrast agent to evaluate microvascular blood flow. By this microbubbles US-researcher devised a ultrasound imaging technique that can spot early signs of PAD.
This May the Brussels-based Crossroads Institute for Cardiac and Vascular Medical Education launched two new educational courses on the prevention of amputation (peripheral vascular disease) and on improving the treatment of women with cardiovascular disease.
Scanning the heart's arteries for calcium deposits might be one of the best ways to predict the overall risk of death for adults with cardiac trouble, a new study suggests. This might also help end the controversial discussions about calcium scans.
Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe. New analysis from Frost & Sullivan point out that the market will grow from $350.0 million in 2007 and to $491.3 million in 2014.
The ankle brachial index, a ratio of blood pressure measurements used to indicate the risk of peripheral artery disease and atherosclerosis, may be useful to improve the accuracy of cardiovascular risk prediction, according to a meta-analysis of previous studies.
Even in 2004, the medical costs for the care of stroke patients in Germany came to 7.1 billion euro. The neurologist Tobias Neumann-Haefelin of the Johann Wolfgang Goethe University in Frankfurt and his colleagues have calculated the projected number of strokes in the German federal state of Hesse for the year 2050.
